Body composition and low blood counts in breast cancer patients receiving chemotherapy

Correlation of Body Composition Measured by Bioelectrical Impedance Analysis and Hematologic Adverse Events in Early-stage Breast Cancer Patients Receiving Chemotherapy

Status

Recruiting

Phases

Phase 2

Study type

Observational

Source

TCTR

Registry ID

TCTR20190702004

Enrollment

150

Registered

2019-07-02

Start date

2019-06-17

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with stage I&#45

Interventions

Stage I&#45

III breast cancer patients who are planned to receive adjuvant or neoadjuvant chemotherapy

Diagnostic

BIA measurement

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Newly diagnosed with stage I, II or III breast cancer 2. Planned to receive (neo)adjuvant chemotherapy consisting of one of the following regimens: cyclophosphamide/doxorubicin (AC), docetaxel/ cyclophosphamide (TC), AC followed by paclitaxel or docetaxel, 5FU/epirubicin/cyclophosphamide (FEC) followed by docetaxel 3. Signed informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with automated implantable cardioverter-defibrillator (AICD), permanent pacemaker or other metallic device 2. Patients known to have pleural effusion, ascites or generalized edema

Design outcomes

Primary

Measure	Time frame
Association of fat free mass index and severe neutropenia After completion of last cycle of chemotherapy Fat free mass measured by BIA device, CBC	—

Secondary

Measure	Time frame
Prognostic impact of fat free mass index and severe neutropenia After completion of last cycle of chemotherapy Receiver Operating Characteristic (ROC) curve	—

Countries

Thailand

Contacts

Public ContactCharuwan Akewanlop

Faculty of Medicine Siriraj Hosptial

charuwan.ake@mahidol.ac.th02 4194489

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026